NEW YORK and SALT LAKE CITY - Citeline announced an expanded partnership with Recursion (NASDAQ:RXRX) on Tuesday to integrate real-world data capabilities into the biotech company’s drug development ...

Recursion is using AI to develop new drug candidates much more efficiently than the overall industry. Tempus AI's $1.27 billion trailing revenue comes from a clinical data flywheel that no competitor ...

A CLI tool that creates IP-netmask address objects on Palo Alto Networks Panorama using the pan-os-python SDK. Address objects are defined in YAML configuration files organized by device group, ...